2019 - Early Translational Research Awards

Limited Submission Funding Opportunity for Texas A&M Faculty and PIs

Cancer Prevention & Research Institute of Texas (CPRIT)

Early Translational Research Awards



Limited Submission Program (LSP): This funding opportunity and the Limited Submission Program (LSP) is open to all Texas A&M University faculty and principal investigators who meet the eligibility requirements. Texas A&M and The Texas A&M University System agencies jointly administer this process to select the proposal(s) that will be submitted to the sponsor in response to this solicitation.


Institutional Eligibility:  The applicant must be a Texas-based entity. Any not-for-profit institution that conducts research is eligible to apply for funding under this award mechanism. However, CPRIT is imposing a limit on the number of ETRA applications that may be submitted by an institution during this review cycle.


PI Eligibility:  The Principal Investigator (PI) must have a doctoral degree, including MD, PhD, DDS, DMD, DrPH, DO, DVM, or equivalent and must reside in Texas during the time the research that is the subject of the grant is conducted.


The proposal will be prepared and submitted by Sponsored Research Services (SRS).


Proposal Limit: 2 for Texas A&M University (includes: Agrilife Research; Engineering Experiment Station); 2 for Texas A&M University Health Science Center


Summary:  The ETRA is intended to bridge the gap between promising new discoveries achieved in the research laboratory and the commercial development of a therapeutic product, medical device, or diagnostic assay through activities up to and including preclinical proof-of-concept data that demonstrate applicability to the planned clinical scenario. The work funded under this RFA must be deemed sufficiently robust such that successful completion would result in a lead product that has compelling evidence of efficacy in qualified models, a favorable preliminary safety profile, and, for therapeutics, evidence of feasibility of scale-up and bulk synthesis. In other words, at the completion of the project it will be clear if the lead product under development has the attributes necessary to attract private investment to continue its development toward IND-enabling studies (IDE-enabling preclinical plan in the case of a medical device) and clinical evaluation




November 1, 2018

Deadline for an email of intent including the title of the internal proposal and a one to three sentence description of the project. 


Send email of intent to limitedsubmissions@tamu.edu

November 7, 2018

Deadline to submit an internal proposal.


All proposals for the LSP must be submitted electronically using the e-proposal on-line application system.


Be prepared to upload your internal proposal. The sections will include a one-three page research plan summary, two-page bio-sketch (per PI), and preliminary budget.


The e-proposal site is password protected. Texas A&M principal investigators may use their NetID and password to access the system. If you do not have a NetID, click HERE for help to activate your NetID. You will need your UIN and your date of birth.  Once you log-in to e-proposal, choose “;Limited Submission Grant”; from the Available Grants section.

If you have any questions, please contact:

 shelly.martin@tamu.edu  or 979.862.2233.


December 5, 2018

Target date for the notifications to PIs of the result of the internal competition.

January 30, 2019

Sponsor deadline for the full proposal.



Internal Selection Procedures:

Texas A&M has established a procedure to identify limited submission opportunities and internally select proposals for Texas A&M submissions.  Please contact us if you have any questions about the limited submission process.